Glyburide
Product Images NDC 66336-712

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 66336-712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0712-xx (Ndc 66336 0712 Xx Teva)

This is a bulk source of Glyburide tablets, manufactured for Teva Pharmaceuticals USA, that are dark blue, oval-shaped with a flat face and beveled-edge compressed. Each tablet contains 6mg of micronized Glyburide USP. Tablest are packaged in a light resistant container and it is recommended to take them orally, with your first meal of the day, avoiding alcohol as it can cause photosensitivity. The product should be kept at a temperature of 68°- 77° F, out of children's reach. The RX# is 32908827 and it is packaged exclusively by Dispensing & Solutions in Santa Ana, CA.*

FDA Label Image

Glyburide Structural Formula (E7421730 04ec 4577 8ffa 9268e60073f5 01)

FDA Label Image

Figure A: Single-dose Bioavailability Study (E7421730 04ec 4577 8ffa 9268e60073f5 02)

The text describes a graph with two lines representing the concentration of two types of glyburide tablets over time, where the x-axis is time in hours and the y-axis is concentration in ng/mL. The first line represents the concentration of 3 mg micronized glyburide tablets while the second line represents the concentration of 5 mg non-micronized glyburide tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.